Intellectual Property Archive » October, 2004

Intellectual Property - October, 2004

101 articles

• Brand-Name Drug Makers Blame Patent Expirations For Depressed Profits
• Futures Exchanges Face Patent Threat
• Glaxo Wins First Battle In Fight Against Reimportation Of Patented Drugs
• RIAA Sues 750 More Alleged Music Pirates
• Immersion Sues Electro Source Over Technology In $82M Judgment Vs. Sony
• Intellectual Property Disputes Hold Up U.S.-Australian Free Trade Agreement
• FDA Calls For Uniform Name For Biogenerics
• USPTO Grants Trade Dress Protection To Classic Furniture Designs
• Flamel Withdraws Lawsuit Vs. Novo Nordisk
• Fuji Loses Lawsuit Over Digital Camera Patents
• Financial Firms Eye Prospects, Pitfalls In IP
• Ethypharm Sues Bentley Over Trade Secrets
• Canadian Branded Drug Makers Miss R&D Target
• Microsoft Lawyers Face Japanese Antitrust Panel In Dispute Over Patent Non-Assertion Clause
• Foundry To Pay $35M To Settle Nortel Patent Dispute
• Setback For Lexmark In Closely Watched DMCA Case
• Agilent Expands Patent Suit Vs. PixArt Over Optical-Mouse Sensors
• India Government Unveils Details Of Patent Regime Overhaul
• Trial Opens In Australian Music Copyright Suit
• Japan Bill Would Clear Way For IP Securitization
• Bayer Takes License For Homocysteine Assay
• Swiss Activists Form Coalition To Oppose Proposed Patent Law Revisions
• Electronic Check Patent Suit Scheduled For April 2006 Trial
• Expedia Settles Trademark Suit Vs. U.K. Firm
• Genentech Loses Appeal Of $500M Royalties Verdict
• U.S. Constitution Bars Canadian Drug Imports, Research Paper Argues
• Enzo Expected To Net "Hundreds Of Millions" In Royalties From Digene Settlement
• Ampex Files ITC Complaint, Federal Lawsuit Vs. Kodak Unit Over Digital Camera Patents
• Akzo Nobel To Pay $36M In Third Settlement Over Remeron Patent Evergreening
• U.K. House Of Lords Declares Amgen's Erythropoietin Patent Invalid
• Liz Claiborne Settles Texas Trademark Suit Over Counterfeits
• Germany To Oppose E.U. Software Patent Proposal
• USPTO Vows To Hire 900 New Examiners If Congress Passes Fee Bill
• Finnegan Henderson Partner Named New LES President
• IP Courts Gaining Ground Worldwide, Survey Finds
• Howrey Partner Named New AIPLA President
• Shaw Pittman's Taiwanese IP Outpost Forms Strategic Alliance With Local Firm
• U.S. Radio Stations Sign Record $1.7B Licensing Deal
• Judge Agrees To Separate Patent Suit From Antitrust Claims In Hynix Dispute With Rambus
• AFL-CIO Sues AstraZeneca Over Handling Of Prilosec Patent Expiration
• Duane Morris Hires Former Kenyon Partner
• India To Overhaul Patent Regime During Parliament's Winter Session
• Bausch & Lomb Unit Sued Over Patent For Vitrectomy Cutter
• SanDisk Sues STMicroelectronics Over Patents In Federal Court And With ITC
• U.S., Israeli Negotiators Make Progress In Talks On Drug IP Rights
• J&J Unit Sues St. Jude Medical Unit Over Medical Device Patents
• Canadian Space Agency Ordered To Pay $800,000 To Inventor
• Diebold Settles Landmark DMCA Suit In Dispute Over Voting Machines
• Judge Rules TKT Infringes Amgen Erythropoietin Patents
• Digene Agrees To Pay $16M Plus Royalties To Settle Enzo Biochem Patent Suit
• Israel Provoking Global Drug Patent Dispute, E.U. Warns
• Artes Medical Asks EPO, USPTO To Revoke Patents For Sanofi-Aventis Lipoatrophy Treatment
• Judge Orders Rockwell To Pay Golden Voice $3.5M For Infringing Call-Center Patent
• Doctors Who Stole Patient Lists Misappropriated Trade Secrets, Judge Rules
• Bingham Hires Two Venable IP Partners
• U.S. Congress Curbs Tax Breaks For IP Donations
• Eolas Legal Team Wins Key Ruling In Separate Patent Suit Vs. Microsoft
• Judge Clears Alpharma's Generic Neurontin
• Judge Enters Permanent Injunction Vs. Medtronic Units In Patent Suit
• Supreme Court Refuses To Hear Case On DMCA Subpoenas In Piracy Lawsuits
• Strong Job Growth In Copyright Industries, Survey Finds
• U.S. Anti-Piracy Crackdown To Be Modeled On Wars On Drugs, Terrorism
• MediaTek Sues Sunext Over Chip Patents
• Jury Orders Medtronic Unit To Pay $400M In Punitive Damages In Patent Suit
• Tyco Healthcare Unit Sues J&J Unit Over Surgical Scalpel Patents
• Taiwan Sends Envoy To U.S. To Discuss Removal From IP Blacklist
• U.S., Israeli Officials To Tackle Dispute Over Drug Data Exclusivity
• Hatch Eyes Generic Biologics Bill Modeled On E.U. Approach
• Judge Rules For Intel In AMD's Antitrust Suit
• Induce Act Dies In Senate Committee
• Hatch, Waxman Signal Concern About "Authorized Generics"
• RatnerPrestia Partners Leave To Launch IP Group For Stradley Ronon
• Entertainment Industry Asks Supreme Court To Overturn 9th Circuit Copyright Decision
• In Risky Move, Alpharma Launches Generic Neurontin
• Acacia Targets Wi-Fi Hotspot Operators With Newly Purchased Patent Rights
• Sun Pays $92M To Settle Kodak Suit Over Java Patents
• Trade Group Files Suits Against 459 Alleged Music Pirates In Europe
• Hearing On Neurontin Injunction Closes Without Ruling
• Judge Rules For Texas Instruments In Licensing Spat With Qualcomm
• Bausch & Lomb Sues Ocular Sciences Over Contact-Lens Patent
• Honeywell Sues 34 Blue-Chip Electronics Makers Over LCD Patents
• USTR Moves Toward Removing Taiwan From "301" IPR Watch List
• Fish & Richardson Snags Applied Material's IP Head
• eBay Argues District-Court Jury Was Improperly Instructed In Patent Appeal
• Staunch Opponent Of Software Patents Tapped To Draft E.U. Legislation
• Pfizer Sues Poland's Top Drug Maker Over Viagra Knockoff
• Energizer Loses ITC Patent Dispute Vs. Chinese Battery Makers
• U.S. Unveils Initiative To Crack Down On Global Piracy
• U.S. Supreme Court Mulls Rare Review Of Patent Case
• Monsanto Wins 12-Year Patent Interference Dispute At USPTO
• WIPO To Convene Summit To Examine Development Proposal
• AstraZeneca Loses Battle Against Generic Plendil At Federal Circuit
• CollaGenix Sues Over ANDAs For Periostat Generics
• Kodak To Push For $1B In Damages After Jury Finds Sun Infringed Java Patents
• Merck Sues Dr. Reddy's Over ANDA For Propecia Generic
• Akzo Nobel Settles Antitrust Litigation Over Remeron Patents For $59.8M
• Diebold Abused DMCA, District Court Rules
• Trading Technologies Settles Lawsuit Vs. Chicago Broker Over Trading Patent
• Glaxo Faces Another Antitrust Suit Over Relafen Patent
• USPTO Deputy Commissioner Joins Oblon, Spivak
• Burns Doane, Merchant & Gould Call Off Merger Talks